Search research articles
Contact Us
Filters
Showing results (151-160 of 252) with videos related to
Page
of 26
Sort By:
Oncogene
|
June 1, 1994
Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines
Y Sekido, S Bader, F Latif, et al.
Cancer
|
January 1, 1992
A pilot trial of chemohormonal therapy for metastatic prostate carcinoma
N A Dawson, G Wilding, R B Weiss, et al.
Journal of Computer Assisted Tomography
|
September 19, 1997
Imaging features of hereditary papillary renal cancers
P L Choyke, M M Walther, G M Glenn, et al.
The Journal of Surgical Research
|
August 1, 1992
Suramin interference with transforming growth factor-beta inhibition of human renal cell carcinoma in culture
T P Wade, A Kasid, C A Stein, et al.
The Journal of Urology
|
August 1, 1993
Regression of metastatic renal cell carcinoma after cytoreductive nephrectomy
S G Marcus, P L Choyke, R Reiter, et al.
JAMA
|
March 4, 1992
Screening for von Hippel-Lindau disease by DNA polymorphism analysis
G M Glenn, W M Linehan, S Hosoe, et al.
The American Journal of Pathology
|
August 6, 1999
Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype
I A Lubensky, L Schmidt, Z Zhuang, et al.
The Journal of Urology
|
March 21, 2001
Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium
D K Ornstein, M Cinquanta, S Weiler, et al.
The Canadian Journal of Urology
|
September 21, 2001
Retroperitoneoscopic-guided radiofrequency ablation of renal tumors
S E Pautler, C P Pavlovich, I Mikityansky, et al.
Journal of the National Cancer Institute
|
February 2, 1994
Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of "hormone-refractory" prostate cancer
O Sartor, M Cooper, M Weinberger, et al.
Page
of 26
Search research articles
Search
Showing results (151-160 of 252) with videos related to
Sort By:
Page
of 26
Oncogene
|
June 1, 1994
Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines
Y Sekido, S Bader, F Latif, et al.
Cancer
|
January 1, 1992
A pilot trial of chemohormonal therapy for metastatic prostate carcinoma
N A Dawson, G Wilding, R B Weiss, et al.
Journal of Computer Assisted Tomography
|
September 19, 1997
Imaging features of hereditary papillary renal cancers
P L Choyke, M M Walther, G M Glenn, et al.
The Journal of Surgical Research
|
August 1, 1992
Suramin interference with transforming growth factor-beta inhibition of human renal cell carcinoma in culture
T P Wade, A Kasid, C A Stein, et al.
The Journal of Urology
|
August 1, 1993
Regression of metastatic renal cell carcinoma after cytoreductive nephrectomy
S G Marcus, P L Choyke, R Reiter, et al.
JAMA
|
March 4, 1992
Screening for von Hippel-Lindau disease by DNA polymorphism analysis
G M Glenn, W M Linehan, S Hosoe, et al.
The American Journal of Pathology
|
August 6, 1999
Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype
I A Lubensky, L Schmidt, Z Zhuang, et al.
The Journal of Urology
|
March 21, 2001
Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium
D K Ornstein, M Cinquanta, S Weiler, et al.
The Canadian Journal of Urology
|
September 21, 2001
Retroperitoneoscopic-guided radiofrequency ablation of renal tumors
S E Pautler, C P Pavlovich, I Mikityansky, et al.
Journal of the National Cancer Institute
|
February 2, 1994
Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of "hormone-refractory" prostate cancer
O Sartor, M Cooper, M Weinberger, et al.
Page
of 26